TINIDAZOLE Disulfiram-like reaction can occur with alcohol Can cause peripheral neuropathy and seizures with prolonged use. | Nitroimidazole Antibiotic | TINIDAZOLE | safe |
TIOCONAZOLE No significant drug interactions For topical use only not for ophthalmic use. | Antifungal | TIOCONAZOLE | safe |
TIOPRONIN Comprehensive clinical and safety monograph for TIOPRONIN (TIOPRONIN). | Cystine Depleting Agent | TIOPRONIN | caution |
TIOTROPIUM BROMIDE Other anticholinergic drugs can have additive effects Can cause paradoxical bronchospasm and narrow-angle glaucoma. | Anticholinergic | TIOTROPIUM BROMIDE | safe |
TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE Comprehensive clinical and safety monograph for TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE (TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE). | Antineoplastic Agent | TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE | caution |
TIROFIBAN HYDROCHLORIDE Other drugs that affect hemostasis increase bleeding risk Can cause severe bleeding and thrombocytopenia. | Glycoprotein IIb/IIIa Inhibitor | TIROFIBAN HYDROCHLORIDE | safe |
TIROSINT Comprehensive clinical and safety monograph for TIROSINT (TIROSINT). | Thyroid Hormone | TIROSINT | caution |
TIROSINT-SOL Comprehensive clinical and safety monograph for TIROSINT-SOL (TIROSINT-SOL). | Thyroid hormone replacement | TIROSINT-SOL | caution |
TIS-U-SOL Comprehensive clinical and safety monograph for TIS-U-SOL (TIS-U-SOL). | Ophthalmic irrigating solution | TIS-U-SOL | caution |
TIS-U-SOL IN PLASTIC CONTAINER Comprehensive clinical and safety monograph for TIS-U-SOL IN PLASTIC CONTAINER (TIS-U-SOL IN PLASTIC CONTAINER). | Ophthalmic irrigating solution | TIS-U-SOL IN PLASTIC CONTAINER | caution |
TISSUEBLUE Comprehensive clinical and safety monograph for TISSUEBLUE (TISSUEBLUE). | Surgical dye | TISSUEBLUE | caution |
TIVDAK Comprehensive clinical and safety monograph for TIVDAK (TIVDAK). | Antineoplastic agent (antibody-drug conjugate) | TIVDAK | caution |
TIVICAY Comprehensive clinical and safety monograph for TIVICAY (TIVICAY). | Antiretroviral, integrase inhibitor | TIVICAY | caution |
TIVICAY PD Comprehensive clinical and safety monograph for TIVICAY PD (TIVICAY PD). | Antiretroviral, integrase inhibitor | TIVICAY PD | caution |
TIVORBEX Comprehensive clinical and safety monograph for TIVORBEX (TIVORBEX). | Muscle relaxant (alpha-2 agonist) | TIVORBEX | caution |
TIZANIDINE HYDROCHLORIDE Strong CYP1A2 inhibitors (eg fluvoxamine) can significantly increase levels Can cause hypotension and sedation. | Alpha-2 Agonist | TIZANIDINE HYDROCHLORIDE | safe |
TLANDO Comprehensive clinical and safety monograph for TLANDO (TLANDO). | Androgen/hormone replacement | TLANDO | caution |
TNKASE Comprehensive clinical and safety monograph for TNKASE (TNKASE). | Thrombolytic (plasminogen activator) | TNKASE | caution |
TOBI Comprehensive clinical and safety monograph for TOBI (TOBI). | Inhaled aminoglycoside antibiotic | TOBI | caution |
TOBI PODHALER Comprehensive clinical and safety monograph for TOBI PODHALER (TOBI PODHALER). | Inhaled aminoglycoside antibiotic | TOBI PODHALER | caution |
TOBRADEX Comprehensive clinical and safety monograph for TOBRADEX (TOBRADEX). | Ophthalmic antibiotic/steroid combination | TOBRADEX | caution |
TOBRADEX ST Comprehensive clinical and safety monograph for TOBRADEX ST (TOBRADEX ST). | Ophthalmic antibiotic/steroid combination | TOBRADEX ST | caution |
TOBRAMYCIN Other nephrotoxic or ototoxic drugs increase risk of toxicity Monitor peak and trough levels to minimize risk of nephrotoxicity and ototoxicity. | Aminoglycoside Antibiotic | TOBRAMYCIN | avoid |
TOBRAMYCIN AND DEXAMETHASONE Other nephrotoxic or ototoxic drugs increase risk of toxicity Monitor peak and trough levels to minimize risk of nephrotoxicity and ototoxicity. | Aminoglycoside Antibiotic | TOBRAMYCIN AND DEXAMETHASONE | avoid |
TOBRAMYCIN SULFATE Other nephrotoxic or ototoxic drugs increase risk of toxicity Monitor peak and trough levels to minimize risk of nephrotoxicity and ototoxicity. | Aminoglycoside Antibiotic | TOBRAMYCIN SULFATE | avoid |
TOBRAMYCIN SULFATE (PHARMACY BULK) Other nephrotoxic or ototoxic drugs increase risk of toxicity Monitor peak and trough levels to minimize risk of nephrotoxicity and ototoxicity. | Aminoglycoside Antibiotic | TOBRAMYCIN SULFATE (PHARMACY BULK) | avoid |
TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER Other nephrotoxic or ototoxic drugs increase risk of toxicity Monitor peak and trough levels to minimize risk of nephrotoxicity and ototoxicity. | Aminoglycoside Antibiotic | TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | avoid |
TOBRASONE Comprehensive clinical and safety monograph for TOBRASONE (TOBRASONE). | Ophthalmic antibiotic/steroid combination | TOBRASONE | caution |
TOBREX Comprehensive clinical and safety monograph for TOBREX (TOBREX). | Ophthalmic aminoglycoside antibiotic | TOBREX | caution |
TODAY Comprehensive clinical and safety monograph for TODAY (TODAY). | Vaginal contraceptive/spermicide | TODAY | caution |
TOFACITINIB Strong CYP3A4 inhibitors may increase levels Can cause serious infections and increased risk of malignancy. | JAK Inhibitor | TOFACITINIB | avoid |
TOFACITINIB CITRATE Strong CYP3A4 inhibitors may increase levels Can cause serious infections and increased risk of malignancy. | JAK Inhibitor | TOFACITINIB CITRATE | avoid |
TOFIDENCE Comprehensive clinical and safety monograph for TOFIDENCE (TOFIDENCE). | JAK inhibitor | TOFIDENCE | caution |
TOFRANIL Comprehensive clinical and safety monograph for TOFRANIL (TOFRANIL). | Tricyclic antidepressant | TOFRANIL | caution |
TOFRANIL-PM Comprehensive clinical and safety monograph for TOFRANIL-PM (TOFRANIL-PM). | Tricyclic antidepressant | TOFRANIL-PM | caution |
TOLAK Comprehensive clinical and safety monograph for TOLAK (TOLAK). | Antifungal | TOLAK | caution |
TOLAZAMIDE Drugs that increase hypoglycemia risk (eg beta-blockers) Can cause severe and prolonged hypoglycemia. | Sulfonylurea | TOLAZAMIDE | safe |
TOLBUTAMIDE Drugs that increase hypoglycemia risk (eg beta-blockers) Can cause severe and prolonged hypoglycemia. | Sulfonylurea | TOLBUTAMIDE | safe |
TOLCAPONE Nonselective MAOIs are contraindicated Can cause hepatotoxicity requiring frequent liver monitoring. | COMT Inhibitor | TOLCAPONE | safe |
TOLECTIN Comprehensive clinical and safety monograph for TOLECTIN (TOLECTIN). | NSAID | TOLECTIN | caution |
TOLECTIN 600 Comprehensive clinical and safety monograph for TOLECTIN 600 (TOLECTIN 600). | NSAID | TOLECTIN 600 | caution |
TOLECTIN DS Comprehensive clinical and safety monograph for TOLECTIN DS (TOLECTIN DS). | NSAID | TOLECTIN DS | caution |
TOLINASE Comprehensive clinical and safety monograph for TOLINASE (TOLINASE). | Antidiabetic (Sulfonylurea) | TOLINASE | caution |
TOLMETIN SODIUM ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding. | NSAID | TOLMETIN SODIUM | avoid |
TOLSURA Comprehensive clinical and safety monograph for TOLSURA (TOLSURA). | Antifungal (Triazole) | TOLSURA | caution |
TOLTERODINE Strong CYP3A4 inhibitors may increase levels Can cause blurred vision and urinary retention. | Anticholinergic | TOLTERODINE | safe |
TOLTERODINE TARTRATE Strong CYP3A4 inhibitors may increase levels Can cause blurred vision and urinary retention. | Anticholinergic | TOLTERODINE TARTRATE | safe |
TOLVAPTAN Comprehensive clinical and safety monograph for TOLVAPTAN (TOLVAPTAN). | Vaptan (Vasopressin Receptor Antagonist) | TOLVAPTAN | caution |
TONMYA Comprehensive clinical and safety monograph for TONMYA (TONMYA). | Antibiotic (Tetracycline) | TONMYA | caution |
TONOCARD Comprehensive clinical and safety monograph for TONOCARD (TONOCARD). | Antiarrhythmic (Class IB) | TONOCARD | caution |
